Niobium Microsystems | $23,000,000 | (Dec 10, 2025)
Corma | $4,069,327 | (Dec 10, 2025)
Scowtt | $12,000,000 | (Dec 10, 2025)
Generare
France
- Paris, Île-de-France
- 08/10/2024
- Seed
- $5,495,250
Natural products have contributed more than 500 molecules to pharmaceuticals.
However, conventional methods for discovering new natural products are increasingly ineffective.
Generare has developed a revolutionary platform that identifies and expresses a wide range of naturally occurring secondary metabolites, selected by millions of years of bacterial evolution.
This platform allows us to reintroduce these lead molecules into clinical pipelines, reopening a validated avenue for therapeutic innovation.
- Industry Biotechnology Research
- Website https://generare.bio/
- LinkedIn https://www.linkedin.com/company/generare-bioscience/
Related People
Guillaume VandeneschFounder
France -
Paris, Île-de-France
Biotech Engineer with 10+ years exp in innovation & and consulting.
- Successful exit Possible Future 2022 to Capgemini Invent
Launched Generare in March 23' to revolutionize early drug discovery
Generare is a data-driven discovery platform that will revive the field of natural products, bringing this historically successful modality into the clinical pipelines.
Our POC in Nat Coms by Dr. Vincent Libis : http://bit.ly/3RL6JPL
Underlying tech awarded with ERC Starting Grant
More info about Generare available at https://docsend.com/view/dvwzjcj6n4vx36y9
AnySignal | $24,000,000 | (Dec 10, 2025)
AllScale | $5,000,000 | (Dec 10, 2025)
CoreOps.AI | $3,500,000 | (Dec 10, 2025)
BON Credit | $3,500,000 | (Dec 10, 2025)
Opine | $5,000,000 | (Dec 10, 2025)
Rotostitch | $1,000,000 | (Dec 10, 2025)
Buildcheck | $5,900,000 | (Dec 10, 2025)
Diald AI | $3,750,000 | (Dec 10, 2025)
Tuhk Inc. | $6,000,000 | (Dec 10, 2025)